U.S. Markets open in 1 hr 21 mins

Bayer Aktiengesellschaft (BAYRY)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
33.06+0.15 (+0.46%)
At close: 3:59PM EDT
People also watch
BASFYRHHBYSIEGYLRLCYLVMUY
Full screen
Previous Close32.91
Open0.00
Bid0.00 x 0
Ask0.00 x 0
Day's Range0.00 - 0.00
52 Week Range
Volume0
Avg. Volume63,823
Market Cap27B
Beta0.99
PE Ratio (TTM)4.88
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield0.74 (2.23%)
Ex-Dividend Date2017-05-01
1y Target EstN/A
Trade prices are not sourced from all markets
  • Pfizer's Sutent Label Expansion Gets Mixed FDA Committee View
    Zacks2 days ago

    Pfizer's Sutent Label Expansion Gets Mixed FDA Committee View

    Pfizer's (PFE) cancer drug Sutent gets a mixed opinion from an FDA advisory committee regarding a regulatory application, which was filed to expand its label.

  • Market Realist2 days ago

    Monsanto-Bayer Deal Completion Will Be Delayed

    This week, Bayer stated that it expects the Monsanto (MON) acquisition to be delayed. Bayer asked for an extension to January 22.

  • Bayer says needs more time for Monsanto deal approval
    Reuters3 days ago

    Bayer says needs more time for Monsanto deal approval

    German drugs and pesticides group Bayer (BAYGn.DE) said on Tuesday it was now likely to be early next year before it can complete its $66 billion deal to acquire U.S. group Monsanto (MON.N), later than previously expected. The European Commission has been scrutinizing the proposed takeover with a deadline of Jan. 8 but Bayer said in a statement it had asked the regulator for an extension on the investigation to Jan. 22, to which the EU Commission responded by saying it would take a decision shortly. Liam Condon, head of Bayer's Crop Science division, said: "An anticipated closing of the deal in early 2018 is now more likely than end of 2017." He also expressed his confidence that the EU would give the green light.